Skip to main content

Table 1 Patient demographics and clinical and pathological characteristics

From: Predictors of postoperative recurrence of pheochromocytoma: a monocentric study

Variables

Overall

No-recurrence (n = 416)

Recurrence (n = 35)

P value

Age(year)

45.89 ± 14.42

47.61 ± 0.83

36.54 ± 14.41

< 0.001*

Sex

   

0.543

 male

229(50.80%)

209(50.20%)

20(57.1%)

 

 female

222(49.20%)

207(49.80%)

15(42.9%)

 

BMI

24.49 ± 10.98

23.57 ± 13.43

23.56 ± 4.60

0.604

Hypertension

   

0.018

 Present

249(55.20%)

223(53.60%)

26(74.30%)

 

 Absent

202(44.80%)

193(46.40%)

9(25.70%)

 

Diabetes

   

0.643

 Present

118(26.20%)

110(26.40%)

8(22.90%)

 

 Absent

333(73.80%)

306(73.60%)

27(77.10%)

History of pcc recurrence

   

< 0.001*

 Present

19(4.20%)

11(2.60%)

8(22.90%)

 

 Absent

432(95.80%)

405(97.40%)

27(77.10%)

 

Family history of hypertension

   

0.098

 Present

173(38.40%)

155(37.70%)

18(51.40%)

 

 Absent

278(61.60%)

261(62.30%)

17(48.60%)

 

tumor size(cm)

5.0(3.5,7.0)

5.0(3.5,7.0)

6.0(5.8,6.8)

0.447

Ki-67 index

   

0.031*

 < 5

225(49.89%)

213(51.20%)

12(34.29%)

 

 ≥ 5

89(19.73%)

78(18.75%)

11(31.43%)

 

 Unknown

137(30.38%)

125(30.05%)

12(34.29%)

 

Preoperative NE

277.9(111.3,556.2)

289.3(86.1,570.5)

250.1(178.6,739.8)

0.523

Preoperative E

41.7(14.7,121.9)

37.7(11.0,102.7)

80.9(29.4,164.9)

0.503

Preoperative DA

419.6(281.4,681.9)

395.3(277.4,654.9)

524.1(441.7,735.6)

0.124

Tumor side

   

0.036*#

 left

195(43.20%)

182(43.80%)

14(48.10%)

 

 right

215(56.80%)

201(56.20%)

14(51.90%)

 

 Bilateral

33(8.90%)

25(7.90%)

7(20.00%)

 

 Unclassified

8(1.8%)

8(1.9%)

0

 
  1. BMI: Body Mass Index; NE: Norepinephrine; E: Epinephrine; DA: Dopamine
  2. * Significant difference
  3. # p-value from statistical comparison between groups, significant difference observed between Bilateral and Unclassified groups